RxDoctor Payments DataLook up a doctor →

Entyvio: payments to doctors

Payments that named Entyvio as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$131.5M
Providers
28,739
Transactions
273,661
Average per transaction
$480

The per-transaction average — $480 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 28,739 providers the average total is $4,574, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Takeda Pharmaceuticals U.S.A., Inc.$131,369,41799.9%
Takeda$64,5940.0%
Takeda Pharmaceutical Company, Limited$27,6420.0%
Shire North American Group Inc$6310.0%
← All drugs & devices